- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Plandai Biotechnology Acquires Senteeko Tea Estate and the Phytofare™ Production Facility
Plandaí Biotechnology, Inc. (OTCQB:PLPL) now owns 100% of Dunn Roman Holdings Africa (Pty) Ltd, a South African holding and management company operating the Senteeko Tea Estate and the Phytofare™ production facility.
Plandaí Biotechnology, Inc. (OTCQB:PLPL) now owns 100% of Dunn Roman Holdings Africa (Pty) Ltd, a South African holding and management company operating the Senteeko Tea Estate and the Phytofare™ production facility.
As quoted in the press release:
Commenting on the acquisition of the minority holders’ interest, Plandaí Chairman and Chief Executive Officer Roger Duffield commented, “Strategically this acquisition makes sense for us because now we can consolidate all of our South African interests into one company. This eliminates intercompany transfer pricing, which is detrimental to customers, and also avoids the double taxation at the different corporate levels in South Africa. In the early stages of our operations, when we first started rejuvenating the tea estate and designing the factory, it made sense to keep the various aspects of our operations separate and to bring in minority shareholders to assist with financing and Shamile community relations. Now that we are set to commence production and sales, it makes more business sense to consolidate and streamline our operations. This move will result in a marked reduction in overhead, greater margins, and a significant tax savings. The acquisition also means that once we are generating income from our South Africa operations, we get to keep a much greater percentage of it.”
Click here to read the Plandaí Biotechnology (OTCQB:PLPL) press release
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.